
Deciphering Tamoxifen Resistance Mechanisms in Hormone Receptor-Positive Breast Cancer: Insights and Strategies
Reading Time: 2 minutes Introduction to Tamoxifen in Cancer Therapy Tamoxifen has long been a cornerstone in the treatment of hormone receptor-positive breast cancer in both premenopausal and postmenopausal women. As a selective estrogen receptor modulator (SERM), tamoxifen's efficacy hinges on its ability to competitively inhibit estrogen binding to estrogen receptors, thereby impeding the growth-promoting effects of estrogen on the tumor. Despite its success, resistance to tamoxifen remains a significant hurdle, leading to treatment failure and disease progression in a subset of patients. Understanding the mechanisms behind tamoxifen resistance is crucial for developing more effective therapeutic strategies. Genetic and Molecular Bases of Resistance Research...